Bekisopa drilling programme
Drilling was completed in November, supporting the subsequent maiden-resource work. The March 2022 resource release is not backdated to 2021.
AKORA’s cash balance recovered in FY2025 as equity funding exceeded combined operating and exploration cash use. The balance sheet remained concentrated in capitalised exploration, principally Bekisopa. Progress from drilling to project studies is important, but it is not a history of mine production or sales.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
After equity funding and annual spending.
Payments, not the change in carrying value.
Most relates to Bekisopa.
Exploration-stage consolidated result.
The programme moved from Bekisopa drilling to a resource estimate, scoping work and pre-feasibility studies. Capitalised expenditure accumulated as technical work advanced; it should not be read as mineral-sale revenue or an immediately realisable asset value.
The PFS describes a proposed Stage One operation and US-dollar project economics. Those are conditional study outputs, not historical annual production, a funding commitment or cash generated by AKORA. The group’s financial statements in this review remain in Australian dollars.
Drilling was completed in November, supporting the subsequent maiden-resource work. The March 2022 resource release is not backdated to 2021.
The March maiden-resource release followed the previous drilling campaign. New equity receipts supported continuing exploration spending.
The updated scoping study was released in November and a pre-feasibility study commenced in December. Study output remains prospective.
Processing trials and road-route engineering progressed. Non-binding financing indications were not equivalent to completed project funding.
The PFS set out the Stage One development case. Satrokala remained on care and maintenance, and the company continued to depend on equity funding.
Exploration cash spending fell from its FY2024 level while operating cash use increased. Net financing still exceeded both categories combined, rebuilding cash despite a foreign-exchange reduction in the cash reconciliation.
A$ million
AI-generated presentation · values from The five-year funding and expenditure record; no missing values plotted as zero.
A$ million
AI-generated presentation · values from The five-year funding and expenditure record; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net loss | (1.077) | (1.501) | (1.595) | (2.200) | (1.989) |
| Operating cash flow | (1.124) | (1.389) | (1.401) | (1.584) | (1.931) |
| Exploration payments / investing cash flow | (2.998) | (2.204) | (1.425) | (3.163) | (1.360) |
| Net financing cash flow | 0.291 | 3.270 | 3.421 | 4.092 | 3.783 |
| Closing cash | 1.046 | 0.722 | 1.314 | 0.661 | 1.103 |
Years ended 31 December. Exploration payments equal the investing-cash total in these selected statements.
FY2025 financing subtotal is identified from the financing section and its share proceeds less issue costs, not rejected because an extracted label is incomplete.
FY2022 consolidated loss is supported by the statement, later comparison and auditor-related claim; inconsistent narrative amounts are not substituted.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Bekisopa accounts for most of the exploration carrying value. Asset recovery depends on future development or sale, and the auditor treated exploration accounting as a key audit matter. The net-current-asset buffer is much smaller than total equity.
A$ million
AI-generated presentation · values from Assets, equity and working capital; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Assets, equity and working capital; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 8.289 | 9.632 | 11.271 | 13.906 | 15.741 |
| Capitalised exploration and evaluation | 7.215 | 8.891 | 9.933 | 13.219 | 14.519 |
| Total liabilities | 0.629 | 0.189 | 0.177 | 0.363 | 0.197 |
| Total equity | 7.660 | 9.443 | 11.094 | 13.542 | 15.543 |
| Net current assets | 0.440 | 0.552 | 1.162 | 0.323 | 1.024 |
FY2025 total assets are explicitly calculated from reported net assets and total liabilities; exploration is an explicit extracted claim.
Capitalised exploration is an accounting balance, not recoverable cash or the market value of contained iron.
A complete reconciliation of historical retained earnings is not reconstructed from the packet; the selected year-end asset/equity observations are shown directly.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2025 |
|---|---|
| Bekisopa carrying amount | 12.353 |
| Total capitalised exploration | 14.519 |
Bekisopa is included within the group total; these values must not be summed.
The PFS reports US-dollar economics. Those forward-looking project values are not mixed with these Australian-dollar historical accounts.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
New share receipts funded the work programme, with cash raising costs reducing the net contribution. The group described equity as its primary funding source and did not have access to credit facilities. The going-concern disclosure retained material uncertainty if sufficient funding could not be achieved.
The mining permit was formally granted in January 2026 and announced in March, followed by appointment of a corporate-finance adviser. These subsequent milestones are not December 2025 approvals or cash receipts.
A$ million
AI-generated presentation · values from Equity cash received and issue costs; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash from share subscriptions | 0.000 | 3.427 | 3.579 | 4.411 | 4.044 |
| Cash equity-raising costs | 0.000 | (0.157) | (0.158) | (0.318) | (0.261) |
FY2021 share-subscription receipts are explicitly nil, but option exercise provided A$0.291m. It is incorrect to describe that year as having no financing receipts.
Share consideration and shares issued in lieu of fees are not added to cash subscriptions.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.